Epigene Labs designs genomics-driven drug for precision oncology.
Epigene Labs has raised $1.6M in total funding. The most recent round was Convertible Note. The last funding was announced in September 2023.
Epigene Labs's investors include Daphni, European Innovation Council, XAnge, AGORANOV, Majycc Innovation Santé.
Epigene Labs is headquartered in Paris, France.
Epigene Labs designs genomics-driven drug for precision oncology.
Epigene Labs is at the Convertible Note stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Epigene Labs — Funding & Investors." VCBacked, September 29, 2023, https://www.vcbacked.co/company/epigene-labs. Accessed November 13, 2026.
VCBacked. (2023). Epigene Labs — Funding & Investors. Retrieved November 13, 2026, from https://www.vcbacked.co/company/epigene-labs
{{cite web |title=Epigene Labs — Funding & Investors |url=https://www.vcbacked.co/company/epigene-labs |website=VCBacked |access-date=November 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Epigene Labs? Request a listing update